Literature DB >> 3121370

Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes.

N Busso1, M Collart, J D Vassalli, D Belin.   

Abstract

The effect of RU 486, a synthetic steroid that is a powerful antagonist of glucocorticoid hormones, was tested on the transcription of several glucocorticoid-regulated genes in different cell types: inflammatory murine macrophages and two human mammary gland-derived cell lines, MDA-MB-231 and HBL-100. The transcription of genes which are positively regulated by glucocorticoids (e.g., tissue-type plasminogen activator and c-myc in mammary cells, c-fos in macrophages) and that of genes which are negatively regulated by these agents (e.g., urokinase-type plasminogen activator in all three cell types, TNF-a and IL-1 in macrophages) was explored. RU 486 almost completely prevented the effects of dexamethasone on the transcription of these various genes. When added alone, RU 486 had essentially no agonist activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121370     DOI: 10.1016/0014-4827(87)90282-5

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription.

Authors:  J Drouin; M A Trifiro; R K Plante; M Nemer; P Eriksson; O Wrange
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

2.  Characterization of 11β-hydroxysteroid dehydrogenase activities in the renal cell line LLC-PK(1) : Evidence for a third isoform?

Authors:  E Möbus; J J Rob Hermans; E Maser
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

3.  Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge.

Authors:  Margaret R Gyetko; Sudha Sud; Stephen W Chensue
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

4.  The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells.

Authors:  Xia Luo; Ping Yin; John S Coon V; You-Hong Cheng; Ronald D Wiehle; Serdar E Bulun
Journal:  Fertil Steril       Date:  2010-01-08       Impact factor: 7.329

5.  Glucocorticoid (GC)-mediated down-regulation of urokinase plasminogen activator expression via the serum and GC regulated kinase-1/forkhead box O3a pathway.

Authors:  Travis Pew; Min Zou; Deanna R Brickley; Suzanne D Conzen
Journal:  Endocrinology       Date:  2008-01-31       Impact factor: 4.736

6.  Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.

Authors:  J F Cajot; W D Schleuning; R L Medcalf; J Bamat; J Testuz; L Liebermann; B Sordat
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

Review 7.  Tumor necrosis factor as a pharmacological target.

Authors:  Pietro Ghezzi; Anthony Cerami
Journal:  Mol Biotechnol       Date:  2005-11       Impact factor: 2.695

8.  Dexamethasone decreases urokinase plasminogen activator mRNA stability in MAT 13762 rat mammary carcinoma cells.

Authors:  B R Henderson; R F Kefford
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.